FluGen raises $12M Series A for “universal” flu vaccine
Wisconsin startup FluGen is developing a flu vaccine that's meant to protect against mutated forms of the virus. It just raised a $12 million Series A to do so.
Wisconsin startup FluGen is developing a flu vaccine that's meant to protect against mutated forms of the virus. It just raised a $12 million Series A to do so.